{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp06_four_proposal_generalization60_20260803","cell_id":"catalytic_pathway_enablement__nanotechnology","arm":"COMPLETE_PROPOSAL_PORTFOLIO","candidate_id":"cip-nano-acoustic-dispersion-cell-003","proposal_index":3,"version":0,"title":"Regenerable Surface-Acoustic-Wave Cell for Assay-Ready Nanoparticle Dispersions","problem":"Nanomaterial characterization and toxicology laboratories repeatedly convert agglomerated nanoparticle suspensions into assay-ready dispersions. The target state is achievable under existing protocols, but each aliquot must overcome particle-particle adhesion and incomplete wetting. Manual sonication or mixing is adjusted case by case, so nominally comparable aliquots can leave preparation with different agglomerate populations, temperatures, surface conditions, or settling behavior. The recurring barrier is controlled deagglomeration, not synthesis of the primary nanoparticles or authorization of the downstream assay.","actors":["Nanomaterial sample-preparation technician","Nanoparticle characterization scientist","Downstream assay scientist","Surface-acoustic-wave device owner","Laboratory safety officer","Quality-control lead"],"observable_state":"For each aliquot, the laboratory can observe starting concentration and agglomerate distribution, passage count, acoustic power and pulse history, residence time, temperature, flow resistance, bubble or fouling signals, recovered mass, post-treatment size distribution, primary-particle integrity, surface-coating markers, settling or reaggregation during the required assay window, cross-contamination, device queue, and performance over successive cleaning cycles.","consequence":"Inconsistent dispersion preparation can make downstream measurements reflect preparation history rather than the submitted nanomaterial. Repeated manual tuning consumes technician and characterization time, while stronger treatment can create heating, fragmentation, coating loss, contamination, or selective particle retention. Adding more aliquots without a bounded pathway increases preparation and verification queues.","affected_objective":"Produce traceable nanoparticle dispersions that meet existing concentration, agglomerate-size, primary-particle-integrity, surface-condition, contamination, and assay-window stability criteria with less repeated case-specific preparation work.","intervention":"Install a sealed flow cell acoustically coupled to a reusable piezoelectric surface-acoustic-wave transducer. Eligible suspensions enter under a published contract specifying particle family, carrier liquid, concentration range, coating, viscosity, temperature, contaminant limits, and required final state. A validated pulse-and-flow program generates localized acoustic microstreaming intended to lower the mechanical barrier to separating secondary agglomerates without supplying or consuming the nanoparticle material. Treated suspension leaves the cell for independent characterization while the transducer remains available for another aliquot. Between cycles, flush the wetted channel, cool the transducer, inspect for retained mass or surface damage, run a reference response check, and either return, refresh, or retire the facilitator. Meter aliquots to observed thermal, flow, cleaning, and characterization capacity. Compare the pathway against matched untreated, sham-cell, and current-protocol aliquots while measuring the complete output distribution rather than only apparently dispersed material.","structural_mapping":[{"archetype_element":"Target transformation specification","domain_realization":"An eligible agglomerated nanoparticle suspension becomes a recovered dispersion satisfying unchanged concentration, agglomerate-size, primary-particle-integrity, surface-condition, contamination, and assay-window stability criteria."},{"archetype_element":"Activation barrier model","domain_realization":"The hypothesized barrier is the mechanical work and wetting needed to separate secondary agglomerates without damaging primary particles; starting agglomeration and treatment response are measured separately from later settling."},{"archetype_element":"Permitted pathway boundary","domain_realization":"Only approved particles, carrier liquids, concentrations, acoustic settings, temperatures, containment procedures, and downstream uses are allowed; the cell cannot legitimize an unsafe material or relax assay-entry criteria."},{"archetype_element":"Reusable facilitator","domain_realization":"The piezoelectric transducer and validated acoustic program remain separate from the treated suspension and must demonstrate repeatable performance after cooling, cleaning, and reference testing."},{"archetype_element":"Facilitator–substrate interface","domain_realization":"A sealed, versioned flow-cell contract defines feed composition, volume, viscosity, temperature, bubble limits, flow, acoustic pulse, residence time, sampling, and release conditions."},{"archetype_element":"Selectivity rule","domain_realization":"The intended path separates secondary agglomerates while limiting primary-particle fracture, coating removal, heating, oxidation, contamination, selective retention, or concentration change."},{"archetype_element":"Facilitator regeneration cycle","domain_realization":"Each cycle ends with channel flushing, retained-mass inspection, cooling, acoustic-response verification, blank testing, and a ready-state decision."},{"archetype_element":"Turnover capacity model","domain_realization":"Capacity is measured as qualifying dispersion cycles per transducer and unit time, including treatment, cooling, cleaning, blank verification, characterization, queueing, and degradation."},{"archetype_element":"Substrate access condition","domain_realization":"Only suspensions within the validated composition and concentration envelope enter; incompatible, poorly characterized, or unusually viscous samples use the existing full-development route."},{"archetype_element":"Saturation and interference monitor","domain_realization":"Queue depth, duty cycle, transducer temperature, flow resistance, bubble detection, cleaning time, characterization backlog, and output drift distinguish excess inflow from facilitator degradation."},{"archetype_element":"Inhibitor or poison monitor","domain_realization":"Feeds are screened for large debris, incompatible solvents, dissolved gas, unexpected salts, strongly adhering coatings, or contaminants that could foul the channel, damp acoustic coupling, or corrupt later aliquots."},{"archetype_element":"Byproduct and side-pathway guardrail","domain_realization":"Mass recovery, particle-size tails, primary-particle damage, coating markers, temperature excursion, channel-derived contamination, cross-sample carryover, and post-treatment reaggregation are assessed alongside apparent deagglomeration."},{"archetype_element":"Equilibrium neutrality check","domain_realization":"The target dispersion must already be achievable and remain within specifications for the required assay window; transient separation that immediately reaggregates is not credited as a feasible final state."},{"archetype_element":"Baseline and counterfactual measure","domain_realization":"Split aliquots are evaluated untreated, after passage through an unactuated sham cell, after the current preparation protocol, and after acoustic treatment under matched sampling and characterization conditions."},{"archetype_element":"Accountable catalyst steward","domain_realization":"A named device owner controls eligibility, operating versions, duty limits, cleaning validation, cross-contamination response, readiness decisions, access records, and retirement, while the characterization lead independently releases outputs."}],"mechanism_mapping":[{"mechanism_slug":"interface_contract_design","role":"Defines meaningful feed preconditions, protected operating limits, and output guarantees for each suspension engaging the acoustic cell.","counterfactual_removal":"Without the contract, incompatible viscosity, solvent, concentration, or coating conditions could enter the cell, making treatment failure and device degradation difficult to distinguish."},{"mechanism_slug":"catalyst_cofactor_system","role":"Maps the carrier liquid, temperature control, degassing, electrical energy, flow control, cleaning solvent, and characterization capacity required for the transducer to function, while keeping them distinct from the reusable facilitator.","counterfactual_removal":"Without the complement map, apparent leverage could be attributed to the transducer while scarce energy, cooling, solvent, or analytical effort is consumed out of view."},{"mechanism_slug":"inhibitor_and_poison_screen","role":"Screens incoming suspensions and operating conditions for debris, bubbles, incompatible solvents, strong foulants, and contamination before exposure to the flow cell.","counterfactual_removal":"Without upstream screening, one incompatible aliquot could suppress acoustic coupling, foul the channel, or contaminate several later samples."},{"mechanism_slug":"active_site_capacity_dashboard","role":"Displays treatment queue, duty cycle, temperature, flow resistance, bubble state, cleaning status, characterization backlog, and reference-response drift to support manual inflow control.","counterfactual_removal":"Without joint capacity and degradation visibility, high demand could be mistaken for transducer failure, or a degraded cell could continue treating samples because it remains nominally online."},{"mechanism_slug":"turnover_and_selectivity_assay","role":"Measures qualifying dispersion cycles per transducer over time and characterizes recovered, retained, damaged, contaminated, and reaggregated material against matched controls.","counterfactual_removal":"Without multi-cycle turnover and whole-output measurement, particle loss or fragmentation could masquerade as successful deagglomeration, and gradual degradation could remain hidden."},{"mechanism_slug":"catalyst_regeneration_protocol","role":"Specifies flushing, cooling, blank verification, reference-response testing, refresh, and retirement after contamination, fouling, drift, or selectivity loss.","counterfactual_removal":"Without measured restoration and a hard retirement rule, the device would be called reusable even if residue, thermal damage, or coupling decay accumulated across samples."},{"mechanism_slug":"small_safe_to_fail_probe","role":"Contains the first comparison to approved laboratory suspensions, split aliquots, low sample volumes, and precommitted stop conditions before downstream assay use.","counterfactual_removal":"Without a bounded facilitator-on and facilitator-off probe, changes caused by passage, settling, sampling, or ordinary handling could be misattributed to the acoustic facilitator."}],"causal_chain":["Eligible nanoparticle suspensions repeatedly enter preparation with secondary agglomerates that must be separated before characterization or assay.","The feed contract and poison screen exclude conditions that would invalidate the pathway or damage the reusable device.","A bounded acoustic field and controlled residence window create a localized mechanical route for deagglomeration while the transducer remains outside the recovered material stream.","The treated suspension is released and characterized for mass recovery, complete size distribution, primary-particle integrity, surface condition, contamination, and assay-window stability.","Sham-cell and current-protocol controls distinguish acoustic barrier reduction from filtration, settling, thermal exposure, or ordinary handling.","The wetted channel is flushed, the transducer is cooled, and blank and reference checks determine whether the facilitator has returned to a ready state.","Cycle-level turnover, selectivity, temperature, fouling, queue, and downstream load measurements govern subsequent admission, regeneration, refresh, or retirement.","Only repeatable qualifying dispersions across restored cycles, without proportional facilitator loss or shifted harm, support continued use of the pathway."],"baseline":"Split each approved starting suspension into matched aliquots. Leave one untreated, pass one through the identical unactuated flow cell, process one with the laboratory's current sonication or mixing protocol, and process one with the candidate acoustic program. Match elapsed time, sampling, containment, concentration accounting, temperature measurement, characterization methods, and downstream acceptance criteria. Compare the complete particle distribution, mass balance, surface-condition markers, contamination, stability during the required assay window, technician effort, energy and cleaning inputs, and downstream queue effects for every aliquot.","nearest_rivals":["Probe or bath sonication under the existing preparation procedure","Rotor-stator mixing or high-pressure homogenization","Addition of dispersants or surfactants consumed with each aliquot","Reformulation of the nanoparticle coating to prevent agglomeration","Single-use microfluidic mixing cartridges","Rejecting difficult suspensions or accepting a narrower set of nanomaterials","Increasing manual preparation and characterization capacity"],"remaining_contrastive_claim":"If supported, the narrow contrastive claim would be that a retained acoustic transducer repeatedly lowers the controlled-deagglomeration barrier across multiple treatment-and-restoration cycles while preserving particle identity and the existing assay-entry standard. This requires measured reuse, selectivity, regeneration, and mass balance; it is not established by stronger bulk mixing, consumable dispersants, formulation redesign, selective particle loss, relaxed dispersion criteria, or additional preparation capacity.","authority_safety":{"decision_authority":"The laboratory's nanoparticle-preparation lead and acoustic-device owner may jointly authorize the contained probe after safety review. The characterization lead independently determines whether treated suspensions meet unchanged release criteria, and the downstream assay owner retains authority to refuse them.","authorized_first_step":"Run a closed-system bench comparison on small split aliquots of pre-characterized, already approved nanoparticle suspensions, including easy, boundary, and deliberately ineligible feed conditions. Use only witness characterization samples until mass balance, integrity, contamination, cleaning, and ready-state checks have been reviewed.","excluded_actions":["Human, animal, clinical, or environmental exposure","Open handling that could aerosolize nanopowders or treated suspensions","Use of unapproved particles, solvents, concentrations, or acoustic settings","Automatic release of treated suspensions into downstream assays","Relaxation of concentration, integrity, contamination, or stability requirements","Increasing acoustic power or residence time beyond the approved probe envelope","Reusing the cell after failed blank, carryover, damage, or reference-response checks","Interpreting particle loss, settling, or fragmentation as successful dispersion"],"halt_rollback":"Stop actuation, isolate the aliquot, and return subsequent samples to the current preparation route if containment fails, temperature or pressure leaves the approved envelope, bubbles or blockage persist, recovered mass becomes unexplained, primary-particle damage or coating loss appears, channel-derived material is detected, cross-contamination occurs, or regeneration fails its blank or reference check. Preserve samples and logs, decontaminate the channel under the approved procedure, and require cause review plus explicit reauthorization before restart."},"negative_tests":{"strongest_counterevidence":"The unactuated sham cell or the existing preparation protocol produces the same output distribution and stability, showing that passage, settling, sampling, or ordinary mixing—not the acoustic facilitator—explains the result. A reduced apparent agglomerate fraction accompanied by missing mass, primary-particle fragments, stripped coating, or retained large particles would also contradict selective catalytic deagglomeration.","problem_falsifier":"The inferred problem is falsified if controlled observation shows that deagglomeration is not a recurring preparation barrier or source of downstream variability—for example, if starting suspensions already meet the assay criteria and differences arise from primary-particle synthesis, storage degradation, assay biology, or analytical measurement.","intervention_falsifier":"The intervention is falsified if it does not improve qualifying dispersion outcomes beyond baseline uncertainty, cannot process successive aliquots without case-specific redevelopment, consumes or sheds facilitator material proportional to throughput, causes unacceptable heating or particle alteration, fails cleaning and ready-state checks, immediately reaggregates, or merely moves delay into characterization.","risks":["Nanoparticle exposure during loading, sampling, leakage, cleaning, or waste handling","Aerosol generation if containment is breached","Acoustic heating or cavitation altering particles or carrier liquid","Primary-particle fracture or surface-coating removal","Selective retention of large particles creating a misleading size distribution","Fouling, bubble formation, flow blockage, or degraded acoustic coupling","Channel or transducer material contaminating the suspension","Cross-sample carryover after incomplete cleaning","Rapid reaggregation before downstream use","Hidden consumption of cleaning solvent, energy, analytical effort, or disposable wetted components","False confidence from incomplete particle-size or mass-balance measurements","Downstream characterization becoming the new bottleneck"]},"next_evidence_step":"Conduct one pre-registered, closed-system probe using split aliquots from a bounded set of approved suspensions and the untreated, sham-cell, current-protocol, and acoustically actuated conditions. Characterize starting and final mass balance, full particle-size distributions, primary-particle integrity, surface-condition markers, temperature history, channel-derived contamination, short-window reaggregation, and blank carryover. Repeat the treatment-cleaning-reference sequence across multiple aliquots and include one predefined boundary feed to test rerouting rather than forced processing. Establish pass, pause, and retirement thresholds from existing assay limits and measured baseline repeatability rather than assuming an effect size.","prior_art_status":"UNSEARCHED","diversity_from_prior_proposals":"Proposal 1 addressed formation of new gold nanocrystal seeds by lowering a physicochemical nucleation barrier at an immobilized ligand-patterned surface. This proposal instead starts with already synthesized nanoparticles and addresses separation of secondary agglomerates through a reusable acoustic energy-transduction pathway; it neither nucleates particles nor uses a nucleation cartridge. Proposal 2 addressed conversion of CAD designs into electron-beam lithography recipes through a versioned informational compiler, semantic eligibility rules, and specialist exception review. This proposal transforms physical suspensions in a sealed laboratory device, with particle integrity, mass balance, fouling, heating, cleaning, and reaggregation as its defining controls. It can be adopted for nanoparticle sample preparation independently of both nanocrystal synthesis and lithography-recipe preparation.","revision_record":{"parent_version":null,"progress_targets_addressed":["Initial complete proposal at index 3 with explicit contrast against sealed proposals 1 and 2."],"conceptual_changes":["Mapped the catalytic cycle to reusable acoustic deagglomeration of existing nanoparticle suspensions rather than particle nucleation or informational recipe compilation."],"operational_changes":["Defined feed compatibility, sealed treatment, duty and thermal capacity, mass-balance guardrails, cleaning, ready-state verification, independent release, deactivation, and rollback."],"evidence_changes":["Specified a bounded split-aliquot comparison against untreated, sham-cell, and current-protocol controls with repeated treatment-regeneration cycles."],"claim_changes":["Restricted the prospective claim to repeatable, selective acceleration of assay-ready dispersion under unchanged standards; no novelty, prevalence, demand, or effect-size claim is made."]}}